0 projects

EIC-The European Innovation Council (EIC)

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

Awarded: NOK 17.8 mill.

Project Period: 2024-2028

Location: Vestland

CL1-Health

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Awarded: NOK 29.6 mill.

Project Period: 2023-2028

Location: Oslo og 5 andre

CL1-Health

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

The high and growing global burden of cancer urges the need for effective implementation of primary cancer prevention (PCP) programmes targeting modifiable risk factors. However, evidence-based programmes with proven effectiveness under controlled environments often fail when implemented in the r...

Awarded: NOK 1.8 mill.

Project Period: 2023-2027

Location: Vestland

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Determining Genetic Bases of Differential Response to Antipsychotics Using Patient-Derived Neurons

Schizophrenia (SCZ) affects 20 million people worldwide and antipsychotics remain the only effective pharmacological intervention. However, one-third of people with SCZ do not respond to first-line antipsychotic drugs. In the absence of clinical biomarkers to stratify SCZ subtypes, all individual...

Awarded: NOK 3.1 mill.

Project Period: 2023-2025

Location: Vestland

CL1-Health

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS, the lifetime risk to develop various cancers can be as high as 100%, and patients have a 50% chance of transmitting the disease to their offspring. When un...

Awarded: NOK 3.5 mill.

Project Period: 2023-2025

Location: Vestland

CL1-Health

Fostering a European Research Area for Health Research

Fostering a European Research Area for Health Research

Awarded: NOK 15.8 mill.

Project Period: 2022-2029

Location: Vestland og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Multiomics based analysis of brain-gut axis: A search for gastrointestinal disease phenotypes

An intimate yet less known relation between human brain and gut is rapidly emerging as several recent studies have identified various alterations within brain as a result of gastrointestinal disorders and reported comparable variations in gastrointestinal system due to altered brain outputs. Thes...

Awarded: NOK 2.1 mill.

Project Period: 2020-2022

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Awarded: NOK 8.6 mill.

Project Period: 2020-2025

Location: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Living well, dying well. A research programme to support living until the end

Every year around 4 million people die in the EU as a result of chronic disease and illness. Many will die in pain or distress, die alone, and die without appropriate health or social care. How we care for the dying is perhaps the most pressing personal, social and public health issue of the 21st...

Awarded: NOK 3.3 mill.

Project Period: 2019-2022

Location: Vestland

H20-ERC-European Research Council

Oral bacteria as determinants for respiratory health

Oral bacteria as determinants for respiratory health

Awarded: NOK 14.4 mill.

Project Period: 2019-2023

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

conect4children (COllaborative Network for European Clinical Trials For Children)

conect4children (COllaborative Network for European Clinical Trials For Children)

Awarded: NOK 6.5 mill.

Project Period: 2018-2024

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Personalised maxillofacial bone regeneration

Personalised maxillofacial bone regeneration

Awarded: NOK 9.1 mill.

Project Period: 2018-2021

Location: Vestland og 2 andre

H20-INFRA-Research infrastructures

Paediatric Clinical Research Infrastructure Network

Paediatric Clinical Research Infrastructure Network

Awarded: NOK 0.45 mill.

Project Period: 2017-2021

Location: Trøndelag - Trööndelage og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

Awarded: NOK 5.1 mill.

Project Period: 2016-2019

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia

Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia

Awarded: NOK 2.4 mill.

Project Period: 2016-2020

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Dynamic hormone diagnostics

Dynamic hormone diagnostics

Awarded: NOK 16.7 mill.

Project Period: 2015-2020

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Female cancer prediction using cervical omics to individualise screening and prevention

While prevention of most female specific cancers (ovarian, breast, endometrial) has not progressed substantially in recent years, significant progress has been made with cervical cancer due to accessibility of the cell of origin (cervical smear) and availability of a test for the causal agent (hu...

Awarded: NOK 2.3 mill.

Project Period: 2015-2020

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Aging Lungs in European Cohorts

Aging Lungs in European Cohorts

Awarded: NOK 4.6 mill.

Project Period: 2015-2019

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts

Today there is no regenerative therapy available for treatment of complete spinal cord injuries (SCI). BioArctic Neuroscience develops a novel treatment of complete SCI. The method is based on the regeneration of functional nerves in the injured spinal cord. Nerve grafts are transplanted into the...

Awarded: NOK 8.1 mill.

Project Period: 2015-2019

Location: Vestland

SECURITY-1.10 Security

Online and Mobile Communications for Emergencies

-

Awarded: NOK 1.5 mill.

Project Period: 2014-2017

Location: Hordaland

SECURITY-1.10 Security

Online and Mobile Communications for Crisis Response and Search and Rescue

Online and Mobile Communications for Crisis Response and Search and Rescue

Awarded: NOK 0.87 mill.

Project Period: 2013-2015

Location: Hordaland